Cargando…
Vaccination during pregnancy: current and possible future recommendations
Immunizing pregnant women to protect the mother, fetus and infant from infection has increasingly been used over the last decade. Protection against infectious diseases in neonates is mainly provided by maternal antibodies transferred from mother to infant during pregnancy through transplacental tra...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222942/ https://www.ncbi.nlm.nih.gov/pubmed/31912233 http://dx.doi.org/10.1007/s00431-019-03563-w |
_version_ | 1783533677096992768 |
---|---|
author | Maertens, Kirsten Orije, Marjolein Rozemarie Paulien Van Damme, Pierre Leuridan, Elke |
author_facet | Maertens, Kirsten Orije, Marjolein Rozemarie Paulien Van Damme, Pierre Leuridan, Elke |
author_sort | Maertens, Kirsten |
collection | PubMed |
description | Immunizing pregnant women to protect the mother, fetus and infant from infection has increasingly been used over the last decade. Protection against infectious diseases in neonates is mainly provided by maternal antibodies transferred from mother to infant during pregnancy through transplacental transport or after delivery via breastfeeding. Both the transplacental- and breast milk–derived maternal antibodies function as the primary source of protection against infectious diseases in neonates during the first vulnerable weeks of life. During recent infectious disease outbreaks (influenza, pertussis, Zika…) and for other infectious diseases (CMV, GBS…), pregnant women are increasingly identified as an important target for vaccination. For some of these diseases, vaccines are already on the market, and recommended during pregnancy. For others, vaccines are currently under development; furthermore, some are even specifically designed to be administered during pregnancy. Conclusion: This review article provides an overview on the rationale and main mechanism of the maternal vaccination strategy and gives a summary about the current and possible future recommendations for maternal vaccination. |
format | Online Article Text |
id | pubmed-7222942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-72229422020-05-15 Vaccination during pregnancy: current and possible future recommendations Maertens, Kirsten Orije, Marjolein Rozemarie Paulien Van Damme, Pierre Leuridan, Elke Eur J Pediatr Review Immunizing pregnant women to protect the mother, fetus and infant from infection has increasingly been used over the last decade. Protection against infectious diseases in neonates is mainly provided by maternal antibodies transferred from mother to infant during pregnancy through transplacental transport or after delivery via breastfeeding. Both the transplacental- and breast milk–derived maternal antibodies function as the primary source of protection against infectious diseases in neonates during the first vulnerable weeks of life. During recent infectious disease outbreaks (influenza, pertussis, Zika…) and for other infectious diseases (CMV, GBS…), pregnant women are increasingly identified as an important target for vaccination. For some of these diseases, vaccines are already on the market, and recommended during pregnancy. For others, vaccines are currently under development; furthermore, some are even specifically designed to be administered during pregnancy. Conclusion: This review article provides an overview on the rationale and main mechanism of the maternal vaccination strategy and gives a summary about the current and possible future recommendations for maternal vaccination. Springer Berlin Heidelberg 2020-01-07 2020 /pmc/articles/PMC7222942/ /pubmed/31912233 http://dx.doi.org/10.1007/s00431-019-03563-w Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Maertens, Kirsten Orije, Marjolein Rozemarie Paulien Van Damme, Pierre Leuridan, Elke Vaccination during pregnancy: current and possible future recommendations |
title | Vaccination during pregnancy: current and possible future recommendations |
title_full | Vaccination during pregnancy: current and possible future recommendations |
title_fullStr | Vaccination during pregnancy: current and possible future recommendations |
title_full_unstemmed | Vaccination during pregnancy: current and possible future recommendations |
title_short | Vaccination during pregnancy: current and possible future recommendations |
title_sort | vaccination during pregnancy: current and possible future recommendations |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222942/ https://www.ncbi.nlm.nih.gov/pubmed/31912233 http://dx.doi.org/10.1007/s00431-019-03563-w |
work_keys_str_mv | AT maertenskirsten vaccinationduringpregnancycurrentandpossiblefuturerecommendations AT orijemarjoleinrozemariepaulien vaccinationduringpregnancycurrentandpossiblefuturerecommendations AT vandammepierre vaccinationduringpregnancycurrentandpossiblefuturerecommendations AT leuridanelke vaccinationduringpregnancycurrentandpossiblefuturerecommendations |